Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

BJ Slotman; H Tinteren; JO Praag; JL Knegjens; Sharouni SY El; M Hatton; A Keijser; C Faivre-Finn; S Senan

doi:10.1016/S0140-6736(14)61085-0

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

BJ Slotman, H Tinteren, JO Praag, JL Knegjens, Sharouni SY El, M Hatton, A Keijser, C Faivre-Finn, S Senan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	36-42
Journal	The Lancet
Volume	385
DOIs	https://doi.org/10.1016/S0140-6736(14)61085-0
Publication status	Published - 14 Sep 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(14)61085-0

Radiotherapy research changes standard clinical practice and improves survival for patients with small-cell lung cancer
Corinne Faivre-Finn (Participant), Fiona Blackhall (Participant) & Paul Lorigan (Participant)
Impact: Health and wellbeing

Cite this

@article{1ac6365689fc41d9a0028fd8c6e4f9dc,

title = "Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.",

author = "BJ Slotman and H Tinteren and JO Praag and JL Knegjens and El, {Sharouni SY} and M Hatton and A Keijser and C Faivre-Finn and S Senan",

year = "2014",

month = sep,

day = "14",

doi = "10.1016/S0140-6736(14)61085-0",

language = "English",

volume = "385",

pages = "36--42",

journal = "The Lancet",

issn = "0140-6736",

publisher = "The Lancet",

}

TY - JOUR

T1 - Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

AU - Slotman, BJ

AU - Tinteren, H

AU - Praag, JO

AU - Knegjens, JL

AU - El, Sharouni SY

AU - Hatton, M

AU - Keijser, A

AU - Faivre-Finn, C

AU - Senan, S

PY - 2014/9/14

Y1 - 2014/9/14

U2 - 10.1016/S0140-6736(14)61085-0

DO - 10.1016/S0140-6736(14)61085-0

M3 - Article

VL - 385

SP - 36

EP - 42

JO - The Lancet

JF - The Lancet

SN - 0140-6736

ER -

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

UN SDGs

Access to Document

Impacts

Radiotherapy research changes standard clinical practice and improves survival for patients with small-cell lung cancer

Cite this